DK168297B1 - Fremgangsmåde til fremstilling af lavmolekylær heparin ud fra normal heparin - Google Patents

Fremgangsmåde til fremstilling af lavmolekylær heparin ud fra normal heparin Download PDF

Info

Publication number
DK168297B1
DK168297B1 DK036881A DK36881A DK168297B1 DK 168297 B1 DK168297 B1 DK 168297B1 DK 036881 A DK036881 A DK 036881A DK 36881 A DK36881 A DK 36881A DK 168297 B1 DK168297 B1 DK 168297B1
Authority
DK
Denmark
Prior art keywords
heparin
molecular weight
normal
low molecular
acid
Prior art date
Application number
DK036881A
Other languages
Danish (da)
English (en)
Other versions
DK36881A (da
Inventor
Fernando Fussi
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of DK36881A publication Critical patent/DK36881A/da
Application granted granted Critical
Publication of DK168297B1 publication Critical patent/DK168297B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK036881A 1980-01-28 1981-01-27 Fremgangsmåde til fremstilling af lavmolekylær heparin ud fra normal heparin DK168297B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11577880A 1980-01-28 1980-01-28
US11577880 1980-01-28
US15567480 1980-06-02
US06/155,674 US4281108A (en) 1980-01-28 1980-06-02 Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained

Publications (2)

Publication Number Publication Date
DK36881A DK36881A (da) 1981-07-29
DK168297B1 true DK168297B1 (da) 1994-03-07

Family

ID=26813554

Family Applications (1)

Application Number Title Priority Date Filing Date
DK036881A DK168297B1 (da) 1980-01-28 1981-01-27 Fremgangsmåde til fremstilling af lavmolekylær heparin ud fra normal heparin

Country Status (7)

Country Link
US (1) US4281108A (it)
DE (1) DE3102621A1 (it)
DK (1) DK168297B1 (it)
FR (1) FR2474508B1 (it)
GB (1) GB2068011B (it)
IT (1) IT1141954B (it)
NL (1) NL189043C (it)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2619136A (en) * 1950-07-10 1952-11-25 John D Nash Rectangular framework clamp
US2670773A (en) * 1950-12-18 1954-03-02 Edward L Avery Concrete form clamp and anchor holder
US3262595A (en) * 1963-09-27 1966-07-26 Johns Manville Lift truck clamp attachment
DE2827772C3 (de) * 1978-06-24 1981-02-26 Peter Strasser Rahmenspannvorrichtung für die Herstellung rechteckiger Rahmen, insbesondere Bilderrahmen
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
US4692435A (en) * 1978-11-06 1987-09-08 Choay, S.A. Mucopolysaccharide composition having a regulatory action on coagulation, medicament containing same and process of preparation
USRE35770E (en) * 1978-11-06 1998-04-14 Choay, S.A. Oligosaccharides having anti-Xa activity and pharmaceutical compositions containing them
SE449753B (sv) * 1978-11-06 1987-05-18 Choay Sa Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav
FR2440376A1 (fr) * 1978-11-06 1980-05-30 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
US4500519A (en) * 1978-11-06 1985-02-19 Choay S.A. Mucopolysaccharides having biological properties, preparation and method of use
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
US4826827A (en) * 1979-10-05 1989-05-02 Choay S.A. Short chained oligosaccharides having biological properties, a process for making the same and the use thereof as drugs
US4438261A (en) 1980-05-19 1984-03-20 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
US4396762A (en) * 1981-08-24 1983-08-02 Massachusetts Institute Of Technology Heparinase derived anticoagulants
CA1195322A (en) * 1982-07-19 1985-10-15 Eduardo Amaya Process for manufacturing low molecular weight heparins by depolymerization of normal heparin
DE3236578A1 (de) * 1982-10-02 1984-04-26 Bessey & Sohn Gmbh & Co, 7000 Stuttgart Rahmenspanngeraet
FR2538404B1 (it) * 1982-12-28 1985-08-23 Anic Spa
US4533549A (en) * 1983-01-04 1985-08-06 Lasker Sigmund E Antithrombotic agent
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
FR2543145B1 (fr) * 1983-03-24 1986-10-17 Sanofi Sa Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante
FR2553287B1 (fr) * 1983-10-18 1986-09-12 Choay Sa Compositions a base de mucopolysaccharides ou d'oligosaccharides, notamment a base de fractions ou fragments d'heparine, appropriees au traitement de desordres de la proliferation cellulaire
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US4788307A (en) * 1986-04-30 1988-11-29 Choay S.A. Oligosaccharidic fractions devoid or practically devoid of antithrombotic activity
US4745107A (en) * 1986-08-20 1988-05-17 Foley Kevin M Heparin derivatives with improved permeability
US4745106A (en) * 1986-08-20 1988-05-17 Griffin Charles C Heparin derivatives having improved anti-Xa specificity
US4745105A (en) * 1986-08-20 1988-05-17 Griffin Charles C Low molecular weight heparin derivatives with improved permeability
US4942156A (en) * 1986-08-20 1990-07-17 Hepar Industries, Inc. Low molecular weight heparin derivatives having improved anti-Xa specificity
IT1230582B (it) 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
CZ232593A3 (en) * 1991-05-02 1994-07-13 Yeda Res & Dev Pharmaceutical preparation for preventing and/or therapy of pathological states
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
CA2235223A1 (en) 1995-10-30 1997-05-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase i
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
CA2341412A1 (en) * 1998-08-27 2000-03-09 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
US6597996B1 (en) * 1999-04-23 2003-07-22 Massachusetts Institute Of Technology Method for indentifying or characterizing properties of polymeric units
AU4351201A (en) * 2000-03-08 2001-09-17 Massachusetts Inst Technology Heparinase iii and uses thereof
KR20000053816A (ko) * 2000-04-20 2000-09-05 조석형 저분자 다당류 및 그의 올리고당 제조방법
ES2324701T3 (es) * 2000-09-12 2009-08-13 Massachusetts Institute Of Technology Metodos y productos relacionados con heparina de peso molecular bajo.
WO2002032406A2 (en) * 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US7084118B2 (en) 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin
US20040122354A1 (en) * 2002-09-05 2004-06-24 Semba Charles P. Infusion catheter having an integrated doppler transducer
EP3997238A1 (en) 2019-07-09 2022-05-18 Optimvia, LLC Methods for synthesizing anticoagulant polysaccharides
EP4182452A1 (en) 2020-07-14 2023-05-24 Optimvia, LLC Methods for synthesizing non-anticoagulant heparan sulfate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB867064A (en) * 1959-05-16 1961-05-03 Roussel Uclaf New derivatives of heparin and processes for their production
NL286444A (it) * 1961-12-08
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche

Also Published As

Publication number Publication date
DK36881A (da) 1981-07-29
GB2068011B (en) 1983-07-27
US4281108A (en) 1981-07-28
DE3102621A1 (de) 1981-12-10
FR2474508A1 (fr) 1981-07-31
DE3102621C2 (it) 1992-08-06
FR2474508B1 (fr) 1986-03-07
GB2068011A (en) 1981-08-05
IT1141954B (it) 1986-10-08
NL189043C (nl) 1992-12-16
NL8100354A (nl) 1981-08-17
NL189043B (nl) 1992-07-16
IT8119321A0 (it) 1981-01-26

Similar Documents

Publication Publication Date Title
DK168297B1 (da) Fremgangsmåde til fremstilling af lavmolekylær heparin ud fra normal heparin
JP3287363B2 (ja) 低分子量多糖類の混合物、及びその製造と利用
WO2021120521A1 (zh) 一种超低分子量透明质酸及其制备方法
US4981955A (en) Depolymerization method of heparin
US4533549A (en) Antithrombotic agent
JPS59133202A (ja) 解重合及び超硫酸化ヘパリン、その製造方法並びに製薬組成物
EP1270599B1 (en) Salmon-origin chondroitin sulfate
JP2001522385A (ja) N−硫酸化ヒアルロン酸化合物、その誘導体および製造方法
KR20140113652A (ko) 반복 다이사카라이드 단위를 포함하는 비-항응고 글리코스아미노글리칸 및 이의 의학적 용도
DK172798B1 (da) Fremgangsmåde til fremstilling af lavmolekylære hepariner ved depolymerisation af normal heparin
JP2022180509A (ja) ポリ硫酸ペントサン及びポリ硫酸ペントサンの製造方法
JP2006291028A (ja) 低分子ヘパリンまたはその塩、ならびにその製造方法
CN111228296A (zh) 一种交联透明质酸依克多因等渗创口冲洗液
JP2628507B2 (ja) Edta不含のヘパリン、ヘパリン分画ならびに断片、それらの製造法及びそれらを含有する医薬品組成物
JP4051099B2 (ja) 低分子化ヘパリン、その製造法及び医薬組成物
US2832766A (en) Sulfated aminopolysaccharides
CA2489862C (en) Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation
JP4954491B2 (ja) コンドロイチンの硫酸化方法
BR112013029765B1 (pt) sulfato de condroitina similar ao de tubarão e processo para o preparo do mesmo
CN104725532B (zh) 一种精确定量控制肝素/类肝素中硫酸软骨素及硫酸皮肤素含量的方法
JPH0128044B2 (it)
JP4719878B2 (ja) アオヤギ由来のコンドロイチン硫酸
JP2023516330A (ja) 生態学的に許容され得る溶媒中での多糖類の直接硫酸化のための方法
CN110878129A (zh) 一种氨基葡萄糖肝素盐及其应用
US2729633A (en) Sulfated pectic acid blood anticoagulant

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired